Henry Ellenbogen’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104M Sell
2,627,321
-4,638,532
-64% -$187M 1.01% 24
2026
Q1
$323M Buy
7,265,853
+365,853
+5% +$16.2M 3.33% 8
2025
Q4
$290M Buy
+6,900,000
New +$291M 2.74% 14

Other funds holding MDLN

Henry Ellenbogen's MDLN Position: Q2 2026 in Review

Henry Ellenbogen reduced its Medline Inc (MDLN) stake by 64% in Q2 2026, selling an estimated $187M and leaving 2,627,321 shares worth $104M. The position accounts for 1.01% of the portfolio, ranked #24.

Henry Ellenbogen first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $323M in Q1 2026. 405 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Henry Ellenbogen held 2,627,321 shares of Medline Inc worth $104M as of Q2 2026.
  • Henry Ellenbogen sold 4,638,532 Medline Inc shares in Q2 2026, an estimated $187M.
  • Medline Inc made up 1.01% of Henry Ellenbogen's portfolio in Q2 2026, its #24 holding.
  • Henry Ellenbogen first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Henry Ellenbogen's Medline Inc position peaked at $323M in Q1 2026.
  • 405 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Durable Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.